| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.425 | 0.024 | 0.693 | HERG channel blocker | 0.141 0.14 DBMET03658 0.325 0.043 DBMET02204 0.693 0.005 DBMET02205 0.28 0.055 DBMET02213 0.36 0.035 DBMET02214 | DBMET02205 | |
| 0.422 | 0.023 | 0.668 | Potassium channel (Voltage-sensitive) blocker | 0.144 0.142 DBMET03658 0.33 0.041 DBMET02204 0.668 0.005 DBMET02205 0.276 0.057 DBMET02213 0.333 0.04 DBMET02214 | DBMET02205 | |
| 0.367 | 0.005 | 0.449 | Hedgehog signaling inhibitor | 0.216 0.009 DBMET03658 0.275 0.005 DBMET02204 0.449 0.004 DBMET02205 0.249 0.007 DBMET02213 0.164 0.019 DBMET02214 | DBMET02205 | |
| 0.344 | 0.034 | 0.554 | Potassium channel blocker | 0.253 0.065 DBMET02204 0.554 0.008 DBMET02205 0.198 0.094 DBMET02213 0.264 0.06 DBMET02214 | DBMET02205 | |
| 0.389 | 0.11 | 0.406 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.373 0.126 DBMET03658 0.286 0.233 DBMET02204 0.406 0.095 DBMET02205 0.295 0.22 DBMET02213 0.3 0.212 DBMET02214 | DBMET02205 | |
| 0.33 | 0.109 | 0.33 | MAP kinase kinase 6 inhibitor | 0.302 0.134 DBMET03658 0.329 0.109 DBMET02204 0.312 0.124 DBMET02205 0.326 0.112 DBMET02213 0.278 0.158 DBMET02214 | ||
| 0.223 | 0.005 | 0.223 | Smo receptor antagonist | 0.077 0.013 DBMET03658 0.12 0.006 DBMET02204 0.112 0.007 DBMET02205 0.106 0.007 DBMET02213 0.059 0.019 DBMET02214 | ||
| 0.264 | 0.064 | 0.275 | Gastrin inhibitor | 0.218 0.123 DBMET03658 0.234 0.099 DBMET02204 0.275 0.053 DBMET02205 0.248 0.082 DBMET02213 | DBMET02205 | |
| 0.2 | 0.015 | 0.2 | 5 Hydroxytryptamine 3A agonist | 0.135 0.044 DBMET03658 0.146 0.038 DBMET02204 0.161 0.03 DBMET02205 0.154 0.033 DBMET02213 0.104 0.072 DBMET02214 | ||
| 0.187 | 0.005 | 0.187 | Melanin-concentrating hormone receptor 1 antagonist | 0.048 0.043 DBMET03658 0.163 0.005 DBMET02204 0.128 0.008 DBMET02205 0.086 0.018 DBMET02213 | ||
| 0.231 | 0.055 | 0.275 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.203 0.065 DBMET03658 0.18 0.075 DBMET02204 0.275 0.04 DBMET02205 0.162 0.086 DBMET02213 0.168 0.082 DBMET02214 | DBMET02205 | |
| 0.186 | 0.017 | 0.2 | Interleukin 8 antagonist | 0.12 0.061 DBMET03658 0.2 0.013 DBMET02204 0.17 0.023 DBMET02205 0.135 0.045 DBMET02213 0.105 0.086 DBMET02214 | DBMET02204 | |
| 0.202 | 0.034 | 0.202 | Cyclin-dependent kinase 8 inhibitor | 0.17 0.061 DBMET03658 0.157 0.073 DBMET02204 0.196 0.038 DBMET02205 0.129 0.104 DBMET02213 0.139 0.091 DBMET02214 | ||
| 0.234 | 0.069 | 0.249 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.206 0.086 DBMET03658 0.187 0.101 DBMET02204 0.249 0.061 DBMET02205 0.208 0.085 DBMET02213 0.178 0.11 DBMET02214 | DBMET02205 | |
| 0.165 | 0.009 | 0.194 | CXC chemokine receptor antagonist | 0.146 0.011 DBMET03658 0.126 0.015 DBMET02204 0.194 0.005 DBMET02205 0.121 0.017 DBMET02213 0.091 0.029 DBMET02214 | DBMET02205 | |
| 0.211 | 0.064 | 0.212 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.156 0.125 DBMET03658 0.212 0.063 DBMET02204 0.205 0.069 DBMET02205 0.211 0.064 DBMET02213 0.15 0.133 DBMET02214 | DBMET02204 | |
| 0.154 | 0.009 | 0.154 | 5 Hydroxytryptamine 3 antagonist | 0.08 0.024 DBMET02204 0.06 0.035 DBMET02205 0.103 0.017 DBMET02213 0.107 0.016 DBMET02214 | ||
| 0.204 | 0.066 | 0.212 | TRKC antagonist | 0.181 0.078 DBMET03658 0.168 0.087 DBMET02204 0.212 0.062 DBMET02205 0.143 0.107 DBMET02213 | DBMET02205 | |
| 0.165 | 0.027 | 0.214 | Check point kinase 2 inhibitor | 0.13 0.041 DBMET03658 0.14 0.035 DBMET02204 0.214 0.014 DBMET02205 0.13 0.042 DBMET02213 0.135 0.039 DBMET02214 | DBMET02205 | |
| 0.189 | 0.052 | 0.277 | Polo-like kinase-3 inhibitor | 0.161 0.073 DBMET03658 0.176 0.06 DBMET02204 0.179 0.058 DBMET02205 0.174 0.062 DBMET02213 0.277 0.016 DBMET02214 | DBMET02214 | |
| 0.16 | 0.028 | 0.18 | Chemokine receptor antagonist | 0.094 0.07 DBMET03658 0.111 0.054 DBMET02204 0.18 0.022 DBMET02205 0.098 0.065 DBMET02213 | DBMET02205 | |
| 0.163 | 0.035 | 0.313 | Protein kinase (CK2) alpha inhibitor | 0.097 0.079 DBMET03658 0.127 0.058 DBMET02204 0.313 0.01 DBMET02205 0.133 0.053 DBMET02213 | DBMET02205 | |
| 0.218 | 0.091 | 0.231 | Neuropeptide Y2 antagonist | 0.231 0.075 DBMET02205 0.194 0.132 DBMET02213 | DBMET02205 | |
| 0.141 | 0.02 | 0.141 | Acetylcholine nicotinic agonist | 0.098 0.039 DBMET02204 0.098 0.039 DBMET02205 0.085 0.051 DBMET02213 | ||
| 0.126 | 0.009 | 0.133 | Alpha 2 adrenoreceptor agonist | 0.082 0.023 DBMET02204 0.133 0.008 DBMET02205 0.074 0.028 DBMET02213 | DBMET02205 | |
| 0.123 | 0.007 | 0.131 | CC chemokine 3 receptor antagonist | 0.056 0.021 DBMET02204 0.131 0.007 DBMET02205 0.051 0.024 DBMET02213 0.076 0.015 DBMET02214 | DBMET02205 | |
| 0.171 | 0.056 | 0.214 | Protein kinase (CK1) gamma inhibitor | 0.149 0.068 DBMET03658 0.132 0.079 DBMET02204 0.214 0.039 DBMET02205 0.117 0.094 DBMET02213 0.118 0.092 DBMET02214 | DBMET02205 | |
| 0.172 | 0.072 | 0.172 | Sigma receptor agonist | 0.153 0.083 DBMET02204 | ||
| 0.108 | 0.009 | 0.108 | Fatty acid synthase inhibitor | 0.059 0.036 DBMET03658 0.084 0.017 DBMET02204 0.085 0.016 DBMET02205 0.056 0.041 DBMET02213 0.063 0.032 DBMET02214 | ||
| 0.266 | 0.169 | 0.498 | Analgesic | 0.291 0.148 DBMET03658 0.255 0.179 DBMET02205 0.498 0.05 DBMET02214 | DBMET02214 | |
| 0.136 | 0.039 | 0.241 | Protein kinase (CK2) inhibitor | 0.114 0.052 DBMET02204 0.241 0.012 DBMET02205 0.1 0.064 DBMET02213 | DBMET02205 | |
| 0.225 | 0.13 | 0.245 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.245 0.111 DBMET03658 0.202 0.155 DBMET02204 | DBMET03658 | |
| 0.144 | 0.051 | 0.144 | TRKB antagonist | 0.113 0.082 DBMET03658 0.132 0.06 DBMET02204 0.137 0.056 DBMET02205 0.113 0.083 DBMET02213 | ||
| 0.153 | 0.061 | 0.163 | Neuropeptide Y1 antagonist | 0.163 0.047 DBMET02205 0.13 0.099 DBMET02213 | DBMET02205 | |
| 0.114 | 0.022 | 0.121 | Tyk2 inhibitor | 0.091 0.031 DBMET03658 0.068 0.043 DBMET02204 0.121 0.02 DBMET02205 0.069 0.042 DBMET02213 0.064 0.045 DBMET02214 | DBMET02205 | |
| 0.154 | 0.062 | 0.154 | Tyrosine-protein kinase receptor antagonist | 0.113 0.094 DBMET02204 0.149 0.064 DBMET02205 | ||
| 0.133 | 0.042 | 0.144 | EphA2 antagonist | 0.144 0.034 DBMET02204 0.137 0.038 DBMET02205 0.117 0.058 DBMET02213 | DBMET02204 | |
| 0.127 | 0.038 | 0.127 | Insulin receptor antagonist | 0.089 0.079 DBMET03658 0.104 0.056 DBMET02204 0.103 0.057 DBMET02205 0.104 0.057 DBMET02213 | ||
| 0.154 | 0.065 | 0.164 | Protein kinase (CK1) gamma 1 inhibitor | 0.135 0.082 DBMET03658 0.13 0.087 DBMET02204 0.164 0.059 DBMET02205 0.122 0.095 DBMET02213 | DBMET02205 | |
| 0.098 | 0.011 | 0.098 | Nicotinic alpha7 receptor agonist | 0.056 0.035 DBMET02204 0.053 0.039 DBMET02205 0.059 0.033 DBMET02213 | ||
| 0.089 | 0.006 | 0.089 | Prolactin release inhibitor | 0.063 0.042 DBMET03658 0.083 0.009 DBMET02204 0.069 0.025 DBMET02205 0.084 0.009 DBMET02213 | ||
| 0.084 | 0.002 | 0.084 | HCV NS5A inhibitor | 0.081 0.003 DBMET03658 0.077 0.003 DBMET02204 0.057 0.004 DBMET02205 0.077 0.003 DBMET02213 0.043 0.005 DBMET02214 | ||
| 0.213 | 0.132 | 0.225 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.225 0.106 DBMET02205 | DBMET02205 | |
| 0.112 | 0.033 | 0.145 | Neuropeptide Y antagonist | 0.145 0.023 DBMET02205 0.076 0.065 DBMET02213 | DBMET02205 | |
| 0.093 | 0.015 | 0.093 | Nicotinic neuronal receptor agonist | 0.065 0.032 DBMET02204 0.069 0.028 DBMET02205 0.054 0.041 DBMET02213 | ||
| 0.18 | 0.103 | 0.18 | EphB2 antagonist | 0.163 0.117 DBMET03658 0.154 0.126 DBMET02204 0.178 0.104 DBMET02205 0.155 0.124 DBMET02213 | ||
| 0.122 | 0.047 | 0.122 | AMP-activated protein kinase stimulant | 0.095 0.077 DBMET02204 0.103 0.066 DBMET02205 | ||
| 0.157 | 0.082 | 0.175 | Protein kinase (CK1) gamma 3 inhibitor | 0.146 0.094 DBMET03658 0.137 0.105 DBMET02204 0.175 0.064 DBMET02205 0.128 0.116 DBMET02213 0.127 0.118 DBMET02214 | DBMET02205 | |
| 0.174 | 0.1 | 0.212 | MAP kinase kinase 2 inhibitor | 0.139 0.131 DBMET03658 0.212 0.074 DBMET02205 | DBMET02205 | |
| 0.1 | 0.028 | 0.1 | Alpha adrenoreceptor agonist | 0.062 0.053 DBMET02204 0.098 0.028 DBMET02205 | ||
| 0.132 | 0.059 | 0.132 | TRKA antagonist | 0.132 0.059 DBMET02205 | ||
| 0.077 | 0.009 | 0.077 | Histamine H4 receptor antagonist | 0.049 0.033 DBMET02204 0.067 0.014 DBMET02205 0.049 0.032 DBMET02213 | ||
| 0.106 | 0.043 | 0.106 | Acetylcholine agonist | |||
| 0.234 | 0.172 | 0.412 | Antiobesity | 0.301 0.116 DBMET02205 0.412 0.061 DBMET02214 | DBMET02214 | |
| 0.098 | 0.036 | 0.172 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.073 0.057 DBMET03658 0.081 0.049 DBMET02204 0.172 0.016 DBMET02205 0.076 0.053 DBMET02213 0.086 0.045 DBMET02214 | DBMET02205 | |
| 0.12 | 0.065 | 0.185 | Protein kinase (CK1) gamma 2 inhibitor | 0.134 0.056 DBMET03658 0.185 0.036 DBMET02205 0.1 0.084 DBMET02214 | DBMET02205 | |
| 0.081 | 0.026 | 0.081 | 5 Hydroxytryptamine 3 agonist | 0.061 0.047 DBMET02205 | ||
| 0.081 | 0.03 | 0.081 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.072 | 0.025 | 0.072 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.066 | 0.02 | 0.075 | Potassium channel (Inward rectifier) blocker | 0.075 0.015 DBMET02205 | DBMET02205 | |
| 0.075 | 0.031 | 0.075 | Janus tyrosine kinase 1 inhibitor | 0.073 0.032 DBMET02205 | ||
| 0.192 | 0.148 | 0.2 | MAP kinase kinase 3 inhibitor | 0.2 0.121 DBMET03658 0.199 0.125 DBMET02205 0.187 0.165 DBMET02213 | DBMET03658 | |
| 0.071 | 0.03 | 0.071 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.111 | 0.07 | 0.111 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.068 | 0.029 | 0.068 | Alpha 1 adrenoreceptor agonist | 0.052 0.048 DBMET02204 | ||
| 0.091 | 0.055 | 0.107 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.088 0.059 DBMET03658 0.107 0.04 DBMET02205 | DBMET02205 | |
| 0.043 | 0.008 | 0.047 | Epoxide hydrolase 2 inhibitor | 0.024 0.017 DBMET03658 0.036 0.011 DBMET02204 0.047 0.006 DBMET02205 0.035 0.011 DBMET02213 0.036 0.011 DBMET02214 | DBMET02205 | |
| 0.13 | 0.095 | 0.13 | Acetylcholine M1 receptor antagonist | |||
| 0.061 | 0.026 | 0.061 | Chemokine receptor agonist | 0.059 0.028 DBMET02205 | ||
| 0.081 | 0.046 | 0.093 | Vanilloid antagonist | 0.093 0.039 DBMET02205 | DBMET02205 | |
| 0.106 | 0.074 | 0.106 | 5 Hydroxytryptamine antagonist | |||
| 0.058 | 0.028 | 0.058 | Dipeptidyl peptidase inhibitor | |||
| 0.073 | 0.043 | 0.073 | Toll-Like receptor 7 antagonist | 0.065 0.05 DBMET02205 | ||
| 0.1 | 0.072 | 0.1 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.039 | 0.012 | 0.039 | Cyclophilin A inhibitor | 0.036 0.015 DBMET03658 0.035 0.016 DBMET02204 0.039 0.013 DBMET02205 0.033 0.018 DBMET02213 0.035 0.016 DBMET02214 | ||
| 0.048 | 0.023 | 0.048 | Dipeptidyl peptidase IV inhibitor | |||
| 0.075 | 0.051 | 0.076 | Adenosine A3 receptor antagonist | 0.076 0.049 DBMET02205 | DBMET02205 | |
| 0.083 | 0.059 | 0.083 | Histamine H2 receptor antagonist | 0.079 0.067 DBMET02204 | ||
| 0.084 | 0.061 | 0.084 | Alpha 2 adrenoreceptor antagonist | |||
| 0.102 | 0.078 | 0.102 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.09 0.086 DBMET02204 | ||
| 0.144 | 0.121 | 0.155 | Death-associated protein kinase 2 inhibitor | 0.155 0.095 DBMET02205 0.139 0.134 DBMET02214 | DBMET02205 | |
| 0.088 | 0.065 | 0.096 | Polo-like kinase-1 inhibitor | 0.092 0.057 DBMET02213 0.096 0.051 DBMET02214 | DBMET02214 | |
| 0.063 | 0.04 | 0.113 | CXC chemokine 4 receptor antagonist | 0.113 0.022 DBMET02205 | DBMET02205 | |
| 0.141 | 0.119 | 0.141 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.061 | 0.04 | 0.064 | Cyclin-dependent kinase 6 inhibitor | 0.064 0.037 DBMET02205 | DBMET02205 | |
| 0.081 | 0.061 | 0.081 | CC chemokine 5 receptor agonist | 0.078 0.07 DBMET02205 | ||
| 0.089 | 0.07 | 0.099 | DNA directed RNA polymerase inhibitor | 0.085 0.077 DBMET03658 0.099 0.058 DBMET02205 | DBMET02205 | |
| 0.107 | 0.088 | 0.132 | MAP kinase 12 inhibitor | 0.102 0.096 DBMET03658 0.132 0.057 DBMET02205 | DBMET02205 | |
| 0.036 | 0.017 | 0.036 | CXC chemokine 3 receptor antagonist | 0.036 0.017 DBMET02205 | ||
| 0.068 | 0.051 | 0.068 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.065 | 0.048 | 0.075 | Vanilloid 1 antagonist | 0.075 0.04 DBMET02205 | DBMET02205 | |
| 0.139 | 0.124 | 0.139 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.039 | 0.025 | 0.063 | DNA gyrase subunit B inhibitor | 0.063 0.008 DBMET02205 | DBMET02205 | |
| 0.065 | 0.051 | 0.109 | Check point kinase 1 inhibitor | 0.109 0.025 DBMET02205 | DBMET02205 | |
| 0.114 | 0.1 | 0.132 | Protein kinase C nu inhibitor | 0.132 0.082 DBMET02205 | DBMET02205 | |
| 0.037 | 0.024 | 0.037 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.068 | 0.057 | 0.126 | MAP kinase 11 inhibitor | 0.126 0.024 DBMET02205 | DBMET02205 | |
| 0.151 | 0.14 | 0.165 | Growth factor agonist | 0.149 0.144 DBMET03658 0.165 0.111 DBMET02204 0.149 0.143 DBMET02205 | DBMET02204 | |
| 0.06 | 0.049 | 0.085 | DNA gyrase inhibitor | 0.057 0.053 DBMET02204 0.085 0.024 DBMET02205 | DBMET02205 | |
| 0.122 | 0.114 | 0.137 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.137 0.098 DBMET03658 | DBMET03658 | |
| 0.051 | 0.043 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.054 | 0.047 | 0.059 | Raf kinase C inhibitor | 0.059 0.043 DBMET02205 | DBMET02205 | |
| 0.095 | 0.089 | 0.118 | MAP kinase 13 inhibitor | 0.118 0.058 DBMET02205 | DBMET02205 | |
| 0.101 | 0.096 | 0.101 | RET inhibitor | |||
| 0.019 | 0.015 | 0.144 | Somatostatin 3 antagonist | 0.018 0.016 DBMET03658 0.144 0.003 DBMET02205 | DBMET02205 | |
| 0.046 | 0.043 | 0.046 | mTOR inhibitor | |||
| 0.127 | 0.124 | 0.132 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.132 0.111 DBMET03658 | DBMET03658 | |
| 0.075 | 0.073 | 0.082 | Stem cell growth factor agonist | 0.076 0.071 DBMET03658 0.082 0.063 DBMET02204 0.074 0.073 DBMET02205 | DBMET02204 | |
| 0.039 | 0.038 | 0.047 | Purinergic P2Y antagonist | 0.047 0.029 DBMET02205 | DBMET02205 | |
| 0.162 | 0.162 | 0.166 | MAP-kinase-activated kinase 5 inhibitor | 0.166 0.156 DBMET02205 | DBMET02205 | |
| 0.135 | 0.137 | 0.154 | I kappa B kinase epsilon inhibitor | 0.138 0.133 DBMET03658 0.139 0.132 DBMET02204 0.154 0.116 DBMET02205 | DBMET02205 | |
| 0.03 | 0.032 | 0.031 | Factor XI inhibitor | 0.031 0.029 DBMET02205 | DBMET02205 | |
| 0.092 | 0.094 | 0.258 | Multidrug resistance-associated protein 1 inhibitor | 0.258 0.005 DBMET03658 0.093 0.091 DBMET02213 | DBMET03658 | |
| 0.14 | 0.142 | 0.164 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.164 0.111 DBMET03658 | DBMET03658 | |
| 0.047 | 0.05 | 0.055 | Lysine-specific demethylase 1A inhibitor | 0.055 0.036 DBMET02205 | DBMET02205 | |
| 0.063 | 0.066 | 0.125 | Rho-associated kinase I inhibitor | 0.125 0.02 DBMET02205 | DBMET02205 | |
| 0.184 | 0.189 | 0.35 | Angiogenesis inhibitor | 0.215 0.153 DBMET02204 0.202 0.167 DBMET02213 0.35 0.071 DBMET02214 | DBMET02214 | |
| 0.026 | 0.033 | 0.036 | Epoxide hydrolase 1 inhibitor | 0.036 0.014 DBMET02205 | DBMET02205 | |
| 0.041 | 0.05 | 0.045 | Neuropeptide Y5 antagonist | 0.045 0.042 DBMET02205 | DBMET02205 | |
| 0.053 | 0.063 | 0.082 | I kappa B kinase 2 inhibitor | 0.082 0.021 DBMET02205 | DBMET02205 | |
| 0.068 | 0.081 | 0.108 | I kappa B kinase inhibitor | 0.108 0.033 DBMET02205 | DBMET02205 | |
| 0.059 | 0.073 | 0.067 | Epoxide hydrolase inhibitor | 0.067 0.058 DBMET02205 | DBMET02205 | |
| 0.055 | 0.073 | 0.08 | Raf kinase inhibitor | 0.066 0.059 DBMET02205 0.08 0.045 DBMET02214 | DBMET02214 | |
| 0.018 | 0.037 | 0.042 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.042 0.011 DBMET02205 | DBMET02205 | |
| 0.075 | 0.094 | 0.092 | MAP kinase kinase kinase inhibitor | 0.092 0.075 DBMET02205 | DBMET02205 | |
| 0.122 | 0.142 | 0.177 | Clk dual-specificity kinase inhibitor | 0.177 0.093 DBMET02205 | DBMET02205 | |
| 0.109 | 0.128 | 0.173 | CDC-like kinase 2 inhibitor | 0.173 0.081 DBMET02205 | DBMET02205 | |
| 0.035 | 0.057 | 0.053 | Poly(ADP-ribose) polymerase inhibitor | 0.053 0.021 DBMET02205 | DBMET02205 | |
| 0.066 | 0.089 | 0.095 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.08 0.072 DBMET02205 0.095 0.058 DBMET02214 | DBMET02214 | |
| 0.072 | 0.096 | 0.086 | MAP kinase 9 inhibitor | 0.086 0.075 DBMET02205 | DBMET02205 | |
| 0.088 | 0.114 | 0.136 | Protein-tyrosine kinase Lyn inhibitor | 0.136 0.073 DBMET02214 | DBMET02214 | |
| 0.05 | 0.077 | 0.095 | CDC7 inhibitor | 0.095 0.026 DBMET02205 | DBMET02205 | |
| 0.15 | 0.181 | 0.164 | ErbB-1 antagonist | 0.164 0.146 DBMET02204 | DBMET02204 | |
| 0.025 | 0.057 | 0.038 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.038 0.026 DBMET02205 | DBMET02205 | |
| 0.186 | 0.221 | 0.249 | Toll-Like receptor 7 agonist | 0.249 0.149 DBMET02204 0.229 0.168 DBMET02214 | DBMET02204 | |
| 0.067 | 0.102 | 0.083 | Vascular endothelial growth factor 1 antagonist | 0.083 0.08 DBMET02214 | DBMET02214 | |
| 0.064 | 0.106 | 0.083 | Platelet activating factor alpha antagonist | 0.083 0.077 DBMET02204 | DBMET02204 | |
| 0.035 | 0.08 | 0.046 | Potassium channel (ATP-sensitive) activator | 0.046 0.037 DBMET02205 | DBMET02205 | |
| 0.036 | 0.083 | 0.048 | Potassium channel (Inward rectifier) activator | 0.048 0.039 DBMET02205 | DBMET02205 | |
| 0.066 | 0.115 | 0.101 | Ephrin antagonist | 0.101 0.062 DBMET02214 | DBMET02214 | |
| 0.179 | 0.23 | 0.241 | Toll-Like receptor agonist | 0.241 0.157 DBMET02204 0.222 0.177 DBMET02214 | DBMET02204 | |
| 0.081 | 0.133 | 0.097 | Activin receptor-like kinase 4 inhibitor | 0.097 0.091 DBMET02205 | DBMET02205 | |
| 0.031 | 0.087 | 0.051 | Raf kinase B inhibitor | 0.051 0.05 DBMET02214 | DBMET02214 | |
| 0.044 | 0.102 | 0.1 | Rho-associated kinase inhibitor | 0.1 0.035 DBMET02205 | DBMET02205 | |
| 0.081 | 0.141 | 0.113 | Ribosomal protein S6 kinase inhibitor | 0.113 0.098 DBMET02205 | DBMET02205 | |
| 0.098 | 0.166 | 0.12 | NOS3 expression enhancer | 0.12 0.115 DBMET02204 | DBMET02204 | |
| 0.06 | 0.163 | 0.217 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.217 0.037 DBMET02214 | DBMET02214 | |
| 0.043 | 0.148 | 0.065 | Heme oxygenase stimulant | 0.065 0.033 DBMET02213 | DBMET02213 | |
| 0.04 | 0.145 | 0.07 | MAP-kinase-activated kinase 2 inhibitor | 0.07 0.057 DBMET02205 | DBMET02205 | |
| 0.045 | 0.159 | 0.078 | MAP-kinase-activated kinase inhibitor | 0.078 0.065 DBMET02205 | DBMET02205 | |
| 0.014 | 0.14 | 0.039 | Phosphodiesterase 3B inhibitor | 0.039 0.038 DBMET02205 | DBMET02205 | |
| 0.068 | 0.223 | 0.175 | Cholinergic | 0.175 0.059 DBMET03658 0.135 0.09 DBMET02214 | DBMET03658 | |
| 0.026 | 0.182 | 0.079 | CDK2/cyclin E2 inhibitor | 0.079 0.039 DBMET02205 | DBMET02205 | |
| 0.058 | 0.236 | 0.116 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.116 0.111 DBMET02205 | DBMET02205 | |
| 0.019 | 0.229 | 0.044 | ATM kinase inhibitor | 0.044 0.013 DBMET02204 | DBMET02204 | |
| 0.13 | 0.402 | 0.24 | Cyclophilin D inhibitor | 0.24 0.225 DBMET02205 | DBMET02205 | |
| 0.074 | 0.392 | 0.154 | Death-associated protein kinase 1 inhibitor | 0.154 0.034 DBMET02205 | DBMET02205 | |
| 0.016 | 0.474 | 0.123 | Bronchodilator | 0.123 0.043 DBMET02214 | DBMET02214 | |
| 0.034 | 0.524 | 0.204 | Tumour necrosis factor alpha release inhibitor | 0.204 0.106 DBMET02214 | DBMET02214 | |
| 0.043 | 0.719 | 0.144 | Lipocortins synthesis antagonist | 0.144 0.115 DBMET02213 | DBMET02213 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |